Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China
· Delayed Price · Currency is CNY 18.42
-0.49 (-2.59%)
Apr 29, 2026, 3:04 PM CST
SHE:002317 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 283.92 | 266.7 | -299.16 | 263.27 | 322.05 | 277.63 | Upgrade
|
| Depreciation & Amortization | 124.83 | 124.83 | 117.9 | 121.15 | 99.57 | 96.02 | Upgrade
|
| Other Amortization | 1.03 | 1.03 | 9.45 | 2.55 | 2.09 | 0.82 | Upgrade
|
| Loss (Gain) From Sale of Assets | -6.05 | -6.05 | -0.03 | -21.68 | -14.69 | 0.63 | Upgrade
|
| Asset Writedown & Restructuring Costs | 51.36 | 51.36 | 500.89 | 30.56 | 2.83 | 2.22 | Upgrade
|
| Loss (Gain) From Sale of Investments | -16.58 | -16.58 | -6.65 | 41.7 | -26.85 | 46.06 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 3.21 | -1.25 | 1.79 | - | Upgrade
|
| Other Operating Activities | 155.25 | 2.31 | 2.68 | 22.6 | 80.6 | 64.79 | Upgrade
|
| Change in Accounts Receivable | -214.1 | -214.1 | -348.14 | -710.08 | -427.22 | 254.02 | Upgrade
|
| Change in Inventory | 71.24 | 71.24 | 24.19 | -39.65 | -29.94 | -54.91 | Upgrade
|
| Change in Accounts Payable | -32.85 | -32.85 | 314.51 | 524.36 | 43.89 | -48.87 | Upgrade
|
| Change in Other Net Operating Assets | 44.86 | 44.86 | 15.82 | -25.73 | - | - | Upgrade
|
| Operating Cash Flow | 475.35 | 305.2 | 337.84 | 190.61 | 63.07 | 622.77 | Upgrade
|
| Operating Cash Flow Growth | 22.30% | -9.66% | 77.24% | 202.23% | -89.87% | 348.25% | Upgrade
|
| Capital Expenditures | -310.13 | -316.17 | -228.26 | -363.06 | -267.96 | -213.76 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.17 | 8.2 | 0.9 | 11.49 | 14.76 | 1.55 | Upgrade
|
| Divestitures | - | - | -0.73 | - | 0.6 | - | Upgrade
|
| Investment in Securities | -48.04 | 332.05 | 565.87 | -410.75 | -279.06 | -477.3 | Upgrade
|
| Other Investing Activities | 20.76 | 22.09 | 46.89 | 19.08 | 4.94 | 4.69 | Upgrade
|
| Investing Cash Flow | -327.25 | 46.16 | 384.67 | -743.24 | -526.73 | -684.83 | Upgrade
|
| Long-Term Debt Issued | - | 327.95 | 301.89 | 1,293 | 1,058 | 399.78 | Upgrade
|
| Total Debt Issued | 297.68 | 327.95 | 301.89 | 1,293 | 1,058 | 399.78 | Upgrade
|
| Long-Term Debt Repaid | - | -304.29 | -725.06 | -1,050 | -583.1 | -608.08 | Upgrade
|
| Total Debt Repaid | -353.88 | -304.29 | -725.06 | -1,050 | -583.1 | -608.08 | Upgrade
|
| Net Debt Issued (Repaid) | -56.2 | 23.66 | -423.17 | 243.2 | 474.89 | -208.3 | Upgrade
|
| Issuance of Common Stock | - | - | 37.08 | 590.2 | 64.06 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -8.93 | -2.63 | -0.16 | -51.6 | Upgrade
|
| Common Dividends Paid | -170.37 | -170.31 | -170.95 | -171.53 | -181.42 | -186.83 | Upgrade
|
| Other Financing Activities | -143.23 | -588.88 | 3.81 | 182.49 | 0.23 | 202.37 | Upgrade
|
| Financing Cash Flow | -369.8 | -735.53 | -562.17 | 841.72 | 357.6 | -244.36 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.05 | -0.03 | 0.02 | 0.4 | 3.16 | -0.83 | Upgrade
|
| Net Cash Flow | -221.74 | -384.19 | 160.36 | 289.49 | -102.9 | -307.25 | Upgrade
|
| Free Cash Flow | 165.22 | -10.97 | 109.58 | -172.44 | -204.89 | 409 | Upgrade
|
| Free Cash Flow Growth | 8.86% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 6.58% | -0.43% | 4.44% | -6.61% | -7.66% | 16.84% | Upgrade
|
| Free Cash Flow Per Share | 0.20 | -0.01 | 0.13 | -0.21 | -0.25 | 0.52 | Upgrade
|
| Cash Income Tax Paid | 195.18 | 190.38 | 225.72 | 215.77 | 206.73 | 231.56 | Upgrade
|
| Levered Free Cash Flow | - | - | 567.53 | 18.6 | -237.88 | 186.71 | Upgrade
|
| Unlevered Free Cash Flow | - | - | 583.37 | 47.92 | -192.03 | 232.85 | Upgrade
|
| Change in Working Capital | -118.41 | -118.41 | 9.55 | -268.3 | -404.32 | 134.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.